Founder and CEO, Pirche AG
Biography
Thomas has more than 25 years of experience and expertise as an entrepreneur working with companies that have a strong technological base. Before Pirche he was the co-founder and former CEO of the biopharmaceutical company "NOXXON Pharma" (EPA: ALNOX), based in Berlin. In 2004, Thomas was co-founder of Arcway (Berlin), the first spin-off from the Hasso-Plattner Institute in Potsdam and served as its chariman until it was sold in 2010. Additionally, Thomas established Be the Partner, LLC based in the USA in 2015 and served for 14 years as the business development advisor and legal representative for all clinical trials in Europe of "Pluristem" (NASDAQ: PSTI), Haifa, a leading provider of cell therapy products.
Clinical & Research Tools Showcase:
Pirche AG
Pirche is a digital diagnostic company working with industry leaders and over 650 clinics globally. With our patented, AI-powered epitope matching platform, we improve clinical outcomes for transplant and oncology patients by providing unparalleled decision support to medical professionals.
Future of Transplant Medicine
Introducing: PIRCHE®—an epitope matching technology using standard testing and cutting-edge artificial intelligence algorithms to support medical professionals.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S2 - January 25 2.45 P.M.-4.00 P.M.,Showcase Track S2 - January 26 1.30 P.M.-4.00 P.M.,Showcase Track S2 - January 27 1.15 P.M.-1.30 P.M.
The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.
